Fundraising FoxGREAT LAKES BAY VENTURE — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
MetaVia is a clinical-stage biotechnology company developing therapeutics for cardiometabolic diseases, including DA-1726 for obesity and vanoglipel (DA-1241) for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
BiotechHealthtechCambridge, US
Mina Sooch(Executive Officer)Hyung Heon Kim(Executive Officer, Director)Margaret McShane(Executive Officer)David Lowenschuss(Executive Officer)Marshall Woodworth(Chief Financial Officer)Charles Bisgaier(Executive Officer)
Board seatKenneth Kousky· per SEC Form D · $12.5M raise · filed Mar 2017
Co-investorsExcel Venture Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.